Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business

Executive Summary

Zeltiq's CoolSculpting body-contouring system will be the third "pillar" in Allergan's aesthetics business, along with its existing facial aesthetics and plastic and regenerative surgery lines, the company says.


Related Content

Allergan Aesthetic Medicines Head Moatazedi Moves To Emerging Competitor Evolus
Atlantic Therapeutics Appoints Former Zeltiq CEO As Chairman
Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017
Full Circle: Allergan's Revenue Growth Fuels Reinvestment In Sales, R&D
M&A Deals Analysis: February Sees Billion-Dollar Buys Bite
Hologic Stitches Medical Aesthetics Into Women's Health
Allergan Adds Accretive Aesthetics Assets In $2.9bn LifeCell Acquisition
How Open Science Is Keeping Allergan's R&D Pipeline Strong


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts